drugset / Trial / NCT03198624

Pharmacokinetics of Oral Capsule in Healthy Japanese vs. Caucasian Subjects

NCT03198624 ↗

Phase 1 Completed 54 enrolled Nxera Pharma UK Limited
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a single and multiple dose, parallel group study to assess safety and pharmacokinetics of oral HTL0018318 in healthy Japanese and Caucasian subjects.

Timeline

Start
2017-05-16
Primary completion
2017-08-20
Completion
2017-08-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator HTL0018318 Unknown — Oral

Indications

No indication recorded.